"India Lacking A Clear Booster Policy": Dr Shahid Jameel
OCIS fellow Dr Shahid Jameel said that global data showed that getting a homologous booster was not the best strategy when India had an array of vaccines to choose from. "Covovax is the next best option if one has been vaccinated with Covishield," he said, considering that the first option of the RNA vaccine was not available in India. "India has approved nine vaccines and manufactures five but largely only uses two."
